8 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... DRUG CLASS, ADVERSE ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy #Table
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Classification: CLASS ... duration: - CLASS ... duration - CLASS ... Vaughan #Williams #Pharmacology ... #pathophysiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Classification: CLASS ... duration - CLASS ... duration - CLASS ... & AP duration CLASS ... #pathophysiology
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics - Sodium Channel ... #Blockers #ClassI ... #Na #cardiology ... #pharmacology # ... table #comparison
Drugs affecting the cardiac action potential. The sharp rise in voltage ("0") corresponds to the influx
Drugs affecting ... to the sodium-channel ... #Pathophys #Pharmacology ... #Cardiology #Antiarrhythmics ... #Classes #Effect
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
Class III Antiarrhythmics ... - Potassium Channel ... a-flutter (when other drugs ... #Blockers #pharmacology ... #cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... tachycardia Calcium Channel ... potential arrhythmias Class ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Class: Selective ... Dosing: 250 mcg tablet ... have been a few changes ... #Indications #Pharmacology